Progenics Pharma (PGNX) Misses Q1 EPS by 5c
Tweet
Share
E-mailGet Alerts PGNX Hot Sheet
Price: $4.10 --0%
Financial Fact:
Operating income (loss): 36.2M
Today's EPS Names:
EDXC, BICX, FBPI, More
Financial Fact:
Operating income (loss): 36.2M
Today's EPS Names:
EDXC, BICX, FBPI, More
Join SI Premium – FREE
Progenics Pharma (NASDAQ: PGNX) reported Q1 EPS of ($0.18), $0.05 worse than the analyst estimate of ($0.13). Revenue for the quarter came in at $2.5 million versus the consensus estimate of $3.27 million.
For earnings history and earnings-related data on Progenics Pharma (PGNX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Walmart (WMT) Tops Q2 EPS by 7c, Beats on Revenue; Offers FY27 EPS Guidance
- Coty (COTY) Misses Q4 EPS by 1c, offers outlook
- Victoria's Secret adds former Starbucks tech chief to its board
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
